Moderna

AGREEMENT GRADE
Fortune 500 Rank
OWLER CEO APPROVAL RATING
61/100
GLASSDOOR RATING
3.5
CEO
Stephane Bancel

Moderna is a biotechnology company focused on pioneering messenger RNA (mRNA) therapeutics and vaccines. Its technology enables the development of treatments and vaccines by instructing cells to produce proteins that help prevent, treat, or cure diseases. Known for its mRNA COVID-19 vaccine, Moderna is expanding its research to target other infectious diseases, cancer, and rare genetic disorders.

AG Sources

COMMENTS

POST A COMMENT